Option chain shows key data for NextPlat's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for NextPlat.

NextPlat (NASDAQ:NXPL) Stock, Option Chain

NextPlat

NextPlat Corp is a global e-commerce and healthcare company. Its e-commerce venues form an effective global network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operate in two segments: e-Commerce Business and Healthcare Business.

chart-1905225

News

NXPL

NextPlat shares are trading higher by 18.8% during Tuesday&#39;s session. The company announced its Board of Directors approved a $2 million share buyback program.

Why NextPlat (NXPL) Stock Is Trading Higher

movers image

Pre-Market Outlook

Markets

Movers

Trading Ideas

AIEV

BENF

CLOV

GHSI

GLMD

KDLY

MOBX

NTBL

QMCO

REVB

ROMA

SNOW

STAF

STEC

URBN

VRAX

WOLF

Why Wolfspeed Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket

Penny Stocks

Small Cap

Intraday Update

ADIL

AEYE

Alterity Therapeutics Limited - American Depositary Shares

ATHE

BHVN

BTCY

CENX

CMAX

Envoy Medical, Inc. - Class A Common Stock

COCH

DXYZ

EGIO

EXTR

HUBC

IMCC

INFA

KAVL

KUKE

LGVN

LOCL

MNDR

MRNS

NMRA

Nuveen California Dividend Advantage Municipal Fund 2

ONVO

PROK

PSNY

QTTB

RARE

RENT

SNGX

SNPO

SPCB

SPWR

SRFM

SWVL

TCON

VERU

VIAO

WIRE

Shares of  Ultragenyx Pharmaceutical Inc.  (NASDAQ: RARE) fell sharply during Monday’s session after the company revealed new data from the Phase 1/2 study of GTX-102 for Angelman syndrome, a genetic disorder causing developmental disabilities and nerve-related symptoms.

Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday&#39;s Mid-Day Session

NextPlat Corp

Earnings

Press Releases

NextPlat Increases 2024 Annual Revenue Guidance to Over $63 Million Representing Growth in Excess of 70% Compared to Fiscal 2023

NextPlat Gains e-Commerce Access to Over 340 Million Consumers with Launch on JD.Com, China's Largest Online Retailer

Contracts

NextPlat's Outfitter Satellite Awarded Three-Year State Government Satellite Enabled Services Contract

NextPlat Board of Directors Approves $2,000,000 Share Buyback Program

Globalstar Partner Global Telesat Communications Sees Massive 35% YoY Growth in SPOT and Satellite IoT Device Sales in 2024

Global Telesat and EVERYWHERE Communications Announce Partnership to Expand Satellite and IoT Connectivity for European Enterprises and Government Agencies

Global Telesat Awarded Satellite-Based Asset Tracking Services Contract from International Humanitarian Aid Organization

NextPlat to Release Full Year 2024 Results on Monday, March 17, 2025

NextPlat Changes the Date of its 2024 Financial Results Report and Investor Conference Call to Monday, March 24, 2025

NextPlat Reports $65.5 Million in Consolidated Year-End 2024 Revenue

GSAT

AST SpaceMobile, Inc. - Class A Common Stock

AST SpaceMobile

Anterix

Bandwidth

Cogent Communications Holdings, Inc. - Common Stock

Cogent Comms Hldgs

Globalstar

Iridium Communications Inc - Common Stock

Iridium Comms

Liberty Global Ltd. - Class A Common Shares

Liberty Global

Liberty Global Ltd. - Class C Common Shares

Liberty Latin America Ltd. - Class A Common Stock

Liberty Latin America

Liberty Latin America Ltd. - Class C Common Stock

Lumen Technologies

Sify Technologies Limited - American Depository Shares, each represented by one Equity Share

Sify Technologies

Comments

NextPlat

NextPlat (NXPL) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga